FIELD: medicine.
SUBSTANCE: it is necessary to carry out intravascular blood photomodification in combination with rhoncoleukin intake. About 3-5 h before the procedure of intravascular blood photomodification it is important to introduce sodium enoxaparine at the dosage of 20 mg subcutaneously into anterior-posterior-lateral area of abdominal wall at lumbar level. The innovation enables to improve laboratory-clinical results of therapy in case of chronic pyelonephritis.
EFFECT: higher efficiency of therapy.
1 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PYOINFLAMMATORY DISEASES AND PREVENTION OF LOCAL NECROTIC AND SEPTICOPYEMIC COMPLICATIONS IN CHILDREN | 2007 |
|
RU2383347C2 |
METHOD FOR APPLYING PHOTOHEMOTHERAPY IN PREPARING PATIENTS FOR EXTRACORPORAL FERTILIZATION | 2003 |
|
RU2307687C2 |
METHOD FOR PREVENTING LIVER INJURIES IN PERFORMING SHOCK-WAVE LITHOTRIPSY | 2006 |
|
RU2321413C1 |
METHOD OF REPERFUSION COMPLICATION PREVENTION IN PATIENTS AFTER OPERATION OF INFERIOR LIMB CHRONIC ISCHEMIA | 2007 |
|
RU2341256C1 |
APPLICATION OF BLOOD PHOTOMODIFICATION IN COMPLEX THERAPY OF VAGINAL CANDIDOSIS | 2002 |
|
RU2277951C2 |
METHOD FOR PROVIDING HIGHER EFFECTIVENESS OF INTERFERON THERAPY OF CHRONIC HEPATITIS C IN CHILDREN | 2011 |
|
RU2468815C1 |
METHOD OF MEDICINAL THERAPY OF DISSEMINATED MALIGNANT NEOPLASMS | 2007 |
|
RU2340355C1 |
METHOD FOR REHABILITATION TREATMENT PATIENTS SUFFERING FROM ROOTED PYELONEPHRITIS | 2005 |
|
RU2297231C2 |
METHOD FOR SELECTING THERAPY FOR CORRECTING LIPID METABOLISM DISORDERS IN CHRONIC PYELONEPHRITIS PATIENTS | 2005 |
|
RU2310864C2 |
METHOD OF TREATING DERMATOSIS AND DETOXICATION AGENT FOR IMPLEMENTING IT | 2013 |
|
RU2558827C2 |
Authors
Dates
2008-03-27—Published
2006-11-29—Filed